Sleep disturbance and impulsive-compulsive behaviours in Parkinson's disease

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 82, Issue 6, 2011, Pages 620-622

  O'Sullivan, Sean S ^a,b   Loane, Clare M ^b   Lawrence, Andrew D ^c   Evans, Andrew H ^d   Piccini, Paola ^b   Lees, Andrew J ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b HAMMERSMITH HOSPITAL   (United Kingdom)

^c CARDIFF UNIVERSITY   (United Kingdom)

^d ROYAL MELBOURNE HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; LEVODOPA;

ADULT; ANXIETY; ANXIETY DISORDER; ARTICLE; BINGE EATING DISORDER; CLINICAL FEATURE; COMPULSION; CONTROLLED STUDY; DEPRESSION; DISEASE SEVERITY; FEMALE; HUMAN; HYPERSEXUALITY; IMPULSIVENESS; MAJOR CLINICAL STUDY; MALE; MANIA; ONSET AGE; PARKINSON DISEASE; PATHOLOGICAL GAMBLING; PRIORITY JOURNAL; PSYCHOMOTOR PERFORMANCE; SLEEP DISORDER;

AGED; ANXIETY; COMPULSIVE BEHAVIOR; DEPRESSION; DOPAMINE AGONISTS; FEMALE; HUMANS; IMPULSIVE BEHAVIOR; MALE; MIDDLE AGED; PARKINSON DISEASE; SLEEP DISORDERS;

EID: 79955777843     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp.2009.186874     Document Type: Article

References (23)

1. Tandberg E, Larsen JP, Karlsen K. A community-based study of sleep disorders in patients with Parkinson's disease. Mov Disord 1998;13:895-9. (Pubitemid 28517665)
2. Voon V, Fox SH. Medication-related impulse control and repetitive behaviors in Parkinson disease. Arch Neurol 2007;64:1089-96. (Pubitemid 47258066)
3. Lawrence AD, Evans AH, Lees AJ. Compulsive use of dopamine replacement therapy in Parkinson's disease: reward systems gone awry? Lancet Neurol 2003;2:595-604.
4. Evans AH, Katzenschlager R, Paviour D, et al. Punding in Parkinson's disease: its relation to the dopamine dysregulation syndrome. Mov Disord 2004;19:397-405. (Pubitemid 38559642)
5. Nausieda PA, Weiner WJ, Kaplan LR, et al. Sleep disruption in the course of chronic levodopa therapy: an early feature of the levodopa psychosis. Clin Neuropharmacol 1982;5:183-94. (Pubitemid 13209012)
6. Boutrel B, Koob GF. What keeps us awake: the neuropharmacology of stimulants and wakefulness-promoting medications. Sleep 2004;27:1181-94. (Pubitemid 39331091)
7. American Sleep Disorders Association. International classification of sleep disorders, revised: diagnostic and coding manual. Rochester, MN: American Sleep Disorders Association, 1997:177-80.
8. Chaudhuri KR, Pal S, DiMarco A, et al. The Parkinson's disease sleep scale: a new instrument for assessing sleep and nocturnal disability in Parkinson's disease. J Neurol Neurosurg Psychiatry 2002;73:629-35. (Pubitemid 35448845)
9. Hirschfeld RM, Williams JB, Spitzer RL, et al. Development and validation of a screening instrument for bipolar spectrum disorder: the mood disorder questionnaire. Am J Psychiatry 2000;157:1873-5.
10. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983;67:361-70. (Pubitemid 13098606)
11. Gomez-Esteban JC, Zarranz JJ, Lezcano E, et al. Sleep complaints and their relation with drug treatment in patients suffering from Parkinson's disease. Mov Disord 2006;21:983-8. (Pubitemid 44184600)
12. Espiritu JR. Aging-related sleep changes. Clin Geriatr Med 2008;24:1-14. (Pubitemid 351491172)
13. Martinez-Martin P, Visser M, Rodriguez-Blazquez C, et al. SCOPA-sleep and PDSS: two scales for assessment of sleep disorder in Parkinson's disease. Mov Disord 2008;23:1681-8.
14. Borek LL, Kohn R, Friedman JH. Mood and sleep in Parkinson's disease. J Clin Psychiatry 2006;67:958-63. (Pubitemid 44049095)
15. Merikangas KR, Akiskal HS, Angst J, et al. Lifetime and 12-month prevalence of bipolar spectrum disorder in the National comorbidity survey replication. Arch Gen Psychiatry 2007;64:543-52. (Pubitemid 46718287)
16. Ryback RS, Schwab RS. Manic response to levodopa therapy. Report of a case. N Engl J Med 1971;285:788-9.
17. Driver-Dunckley ED, Noble BN, Hentz JG, et al. Gambling and increased sexual desire with dopaminergic medications in restless legs syndrome. Clin Neuropharmacol 2007;30:249-55. (Pubitemid 47511504)
18. Pagel JF, Helfter P. Drug induced nightmaresean etiology based review. Hum Psychopharmacol 2003;18:59-67. (Pubitemid 36192959)
19. Gjerstad MD, Boeve B, Wentzel-Larsen T, et al. Occurrence and clinical correlates of REM sleep behaviour disorder in patients with Parkinson's disease over time. J Neurol Neurosurg Psychiatry 2008;79:387-91. (Pubitemid 351441491)
20. Wisor JP, Nishino S, Sora I, et al. Dopaminergic role in stimulant-induced wakefulness. J Neurosci 2001;21:1787-94. (Pubitemid 32184295)
21. Evans AH, Lawrence AD, Potts J, et al. Factors influencing susceptibility to compulsive dopaminergic drug use in Parkinson disease. Neurology 2005;65:1570-4. (Pubitemid 41689470)
22. Schmidt RE, Gay P, Van der Linden M. Facets of impulsivity are differentially linked to insomnia: evidence from an exploratory study. Behav Sleep Med 2008;6:178-92.
23. Frussa-Filho R, Goncalves MT, Andersen ML, et al. Paradoxical sleep deprivation potentiates amphetamine-induced behavioural sensitization by increasing its conditioned component. Brain Res 2004;1003:188-93. (Pubitemid 38317100)